About this trial
The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and the social and mental health factors known to impact maternal outcomes, with the current standard of care and with each other.
Eligibility criteria
Qualifiers
Delivery of singleton live birth (twins reduced to singleton or with vanishing twin syndrome prior to 14 weeks qualify)
Postpartum
English or Spanish speaking
Viable pregnancy 24 weeks of gestation or above (Child can be in NICU to participate)
Disqualifiers
Multifetal pregnancy (since are they at increased risk for key outcomes)
Gestational age <24 weeks;
Known major fetal anomaly in current pregnancy or stillbirth
Actively using illicit/illegal substances (such as cocaine, heroin and other types of illicit opiates such as fentanyl) as noted in delivery hospitalization notes
Trial design
Treatments tested in this trial
- Remote Medical Model (RMM)
- Community Health Model (CHM)
- SoC
Treatment groups
Sponsors and collaborators
Yale University
Lead sponsor
Patient-Centered Outcomes Research Institute
Collaborator